Latest filings (excl ownership)
10-Q
2024 Q3
Quarterly report
14 May 24
8-K
Entry into a Material Definitive Agreement
5 Apr 24
424B5
Prospectus supplement for primary offering
5 Apr 24
8-K
Entry into a Material Definitive Agreement
16 Feb 24
10-Q
2024 Q2
Quarterly report
14 Feb 24
8-K
Submission of Matters to a Vote of Security Holders
19 Jan 24
DEF 14A
Definitive proxy
4 Dec 23
10-Q
2024 Q1
Quarterly report
14 Nov 23
8-K
Other Events
6 Nov 23
10-K
2023 FY
Annual report
13 Oct 23
NT 10-K
Notice of late annual filing
28 Sep 23
8-K
Entry into a Material Definitive Agreement
1 Sep 23
424B5
Prospectus supplement for primary offering
4 Aug 23
8-K
Other Events
25 May 23
EFFECT
Notice of effectiveness
23 May 23
CORRESP
Correspondence with SEC
17 May 23
10-Q
2023 Q3
Quarterly report
15 May 23
UPLOAD
Letter from SEC
12 May 23
S-3/A
Shelf registration (amended)
8 May 23
S-3
Shelf registration
5 May 23
8-K
Entry into a Material Definitive Agreement
31 Mar 23
10-Q
2023 Q2
Quarterly report
14 Feb 23
8-K
Submission of Matters to a Vote of Security Holders
13 Feb 23
DEFA14A
Additional proxy soliciting materials
22 Dec 22
8-K
Submission of Matters to a Vote of Security Holders
22 Dec 22
DEF 14A
Definitive proxy
15 Nov 22
10-Q
2023 Q1
Quarterly report
14 Nov 22
PRE 14A
Preliminary proxy
4 Nov 22
10-K
2022 FY
Annual report
13 Oct 22
8-K
Departure of Directors or Certain Officers
11 Oct 22
NT 10-K
Notice of late annual filing
29 Sep 22
10-Q
2022 Q3
Quarterly report
16 May 22
10-Q
2021 Q2
Quarterly report
14 Feb 22
8-K
Submission of Matters to a Vote of Security Holders
26 Nov 21
10-Q
2021 Q1
Quarterly report
15 Nov 21
10-K
2021 FY
Annual report
12 Oct 21
DEF 14A
Definitive proxy
12 Oct 21
NT 10-K
Notice of late annual filing
28 Sep 21
8-K
Significantly Improved Safety Profile and Metabolism of Remdesivir Observed
21 Sep 21
8-K
NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development
15 Sep 21
Latest ownership filings
4
Anil Diwan
10 Aug 22
SC 13G/A
CVI Investments, Inc.
16 Feb 21
SC 13G/A
Altium Capital Management LP
12 Feb 21
SC 13G/A
Empery Asset Management, LP
26 Jan 21
SC 13G/A
SABBY MANAGEMENT, LLC
4 Jan 21
SC 13G
Altium Capital Management LP
20 Jul 20
SC 13G
CVI Investments, Inc.
29 May 20
3
Makarand Jawadakar
1 May 20
SC 13G
Nanoviricides, Inc.
27 Jan 20
SC 13G/A
Nanoviricides, Inc.
24 Jan 20
3
Mark D. Day
20 Aug 19
SC 13D
Nanoviricides, Inc.
12 Oct 18
4
MILTON BONIUK
11 Oct 18
4
Eugene Seymour
4 May 18
4
MILTON BONIUK
3 Feb 17
4
MILTON BONIUK
24 May 16
4
MILTON BONIUK
18 May 16
4
MILTON BONIUK
5 May 16
4
MILTON BONIUK
2 May 16
4
MILTON BONIUK
24 Feb 16
4
MILTON BONIUK
16 Feb 16
4
MILTON BONIUK
17 Nov 15
4
MILTON BONIUK
23 Oct 15
4
Anil Diwan
24 Sep 15
4
Eugene Seymour
24 Sep 15
4
MILTON BONIUK
15 Sep 15
4
MILTON BONIUK
27 Aug 15
4
MILTON BONIUK
25 Aug 15
4
MILTON BONIUK
10 Jul 15
4
MILTON BONIUK
25 Jun 15
4
MILTON BONIUK
18 Jun 15
4
MILTON BONIUK
21 May 15
4
MILTON BONIUK
12 May 15